Lund, Sweden, 16:00 CET, 13 April 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injuries, announces that the Annual Report for 2020 is now available as a pdf on the group’s web page, www.bonesupport.com. A pdf version is also attached to this press release.
For more information contact:
BONESUPPORT Holding AB
Emil Billbäck, CEO
+46 (0) 46 286 53 70
+46 (0) 708 76 87 87
The information in this press release is such that BONESUPPORT Holding AB (publ) is required to disclose pursuant to the Swedish Securities Market Act (2007: 528) (VpmL). The information was submitted for publication through the agency of the contact persons set out above, at 16:00 CET on 13 April 2021.
BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 181 million in 2020. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.